Rocuronium
- Product NDC
- 63323-426
- 11-digit product format
- 633230426
- Labeler code
- 63323
- Product ID
- 63323-426_3f4d5e11-2c14-4406-8954-04dba2fc65ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ROCURONIUM BROMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA078651
- Marketing category
- ANDA
- Marketing start
- 2009-12-13
- Substance
- ROCURONIUM BROMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rocuronium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ROCURONIUM BROMIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I65MW4OFHZ |
| Rxcui | 1234995 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-426-01 | Rocuronium | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | | 10 |
| 63323-426-02 | Rocuronium | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | | 10 |
| 63323-426-05 | Rocuronium | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | | 10 |
| 63323-426-10 | Rocuronium | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | | 10 |
| 63323-426-12 | Rocuronium | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | | 2 |
| 63323-426-15 | Rocuronium | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ROCURONIUM BROMIDE | ACTIVE INGREDIENT | I65MW4OFHZ | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| ROCURONIUM | ACTIVE MOIETY | WRE554RFEZ | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-426 | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 10 | Current NDC, Legacy NDC, 4 package rows | 20230426_f1933332-1ae0-4dc1-be4c-694849e6c9f9.zip |
| 63323-426 | ROCURONIUM (ROCURONIUM BROMIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20230201_fb9524b2-c353-4747-8954-7ca2529eabb2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-426-01 | 63323042601 | 10 mL in 1 VIAL | 10 ml | | | | | Historical |
| 63323-426-02 | 63323042602 | 5 mL in 1 VIAL | 5 ml | | | | | Historical |
| 63323-426-05 | 63323042605 | 10 VIAL in 1 TRAY (63323-426-05) / 5 mL in 1 VIAL (63323-426-02) | 10 vial | 2009-12-13 | 0000-00-00 | No | No | Current |
| 63323-426-10 | 63323042610 | 10 VIAL in 1 TRAY (63323-426-10) / 10 mL in 1 VIAL (63323-426-01) | 10 vial | 2009-12-13 | 0000-00-00 | No | No | Current |
| 63323-426-12 | 63323042612 | 5 mL in 1 VIAL | 5 ml | | | | | Historical |
| 63323-426-15 | 63323042615 | 10 VIAL in 1 TRAY (63323-426-15) / 5 mL in 1 VIAL (63323-426-12) | 10 vial | 2009-12-13 | | No | No | Historical |